Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All curcumin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchCurcuminCurcumin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

In vitro antiviral activity against SARS-CoV-2 of common herbal medicinal extracts and their bioactive compounds

Leka et al., Phytotherapy Research, doi:10.1002/ptr.7463
Apr 2022  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Curcumin for COVID-19
15th treatment shown to reduce risk in February 2021
 
*, now with p = 0.0000000096 from 27 studies.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,800+ studies for 98 treatments. c19early.org
In Vitro study showing antiviral activity of curcumin longa, with protection against SARS-CoV-2-induced cytopathic effects at a concentration of 3.125μg/ml.
47 preclinical studies support the efficacy of curcumin for COVID-19:
In Silico studies predict inhibition of SARS-CoV-2 with curcumin or metabolites via binding to the spikeA,5,10,12,18,21 (and specifically the receptor binding domainB,8,11,14), MproC,5,7,9-11,13,14,16,19,21,22,24,37, RNA-dependent RNA polymeraseD,11,20, ACE2E,12,13,15, nucleocapsidF,6,23, nsp10G,23, and helicaseH,27 proteins. In Vitro studies demonstrate inhibition of the spikeA,32 (and specifically the receptor binding domainB,40), MproC,17,32,37,39, ACE2E,40, and TMPRSS2I,40 proteins, and inhibition of spike-ACE2 interactionJ,25. In Vitro studies demonstrate efficacy in Calu-3K,38, A549L,32, 293TM,1, HEK293-hACE2N,17,30, 293T/hACE2/TMPRSS2O,31, Vero E6P,7,11,21,30,32-34,36,38, and SH-SY5YQ,29 cells. Curcumin is predicted to inhibit the interaction between the SARS-CoV-2 spike protein receptor binding domain and the human ACE2 receptor for the delta and omicron variants8, decreases pro-inflammatory cytokines induced by SARS-CoV-2 in peripheral blood mononuclear cells36, alleviates SARS-CoV-2 spike protein-induced mitochondrial membrane damage and oxidative stress1, and may limit COVID-19 induced cardiac damage by inhibiting the NF-κB signaling pathway which mediates the profibrotic effects of the SARS-CoV-2 spike protein on cardiac fibroblasts41.
Leka et al., 9 Apr 2022, peer-reviewed, 6 authors.
In Vitro studies are an important part of preclinical research, however results may be very different in vivo.
This PaperCurcuminAll
In vitro antiviral activity against SARS‐CoV ‐2 of common herbal medicinal extracts and their bioactive compounds
Kristi Leka, Carla Hamann, Pauline Desdemoustier, Michel Frédérich, Mutien‐marie Garigliany, Allison Ledoux
Phytotherapy Research, doi:10.1002/ptr.7463
To the Editor, The coronavirus SARS-CoV-2 spread all around the world, leading to an unprecedented pandemic. Up to date, some effective treatments have been highlighted to treat the symptoms, but not to cure the COVID-19 disease. At least, some well-known medicines have been proposed, but have rapidly become the subject of some controversy, such as hydroxychloroquine combined or not azithromycin
FUNDING INFORMATION Fonds Léon Fredericq, Grant/Award Number: 2020-2021 -113 -Sub. F/E; Fondation Hospitalo Universitaire Léon Fredericq. CONFLICT OF INTEREST The authors declare no conflicts of interest.
References
Derosa, Maffioli, D'angelo, Di Pierro, A role for quercetin in coronavirus disease 2019 (COVID-19), Phytotherapy Research, doi:10.1002/ptr.6887
Franco-Paredes, Transmissibility of SARS-CoV-2 among fully vaccinated individuals, The Lancet Infectious Diseases, doi:10.1016/S1473-3099(21)00768-4
Ledoux, Leka, Bonnet, Blanquer, Alembert et al., In vitro antiviral activity against SARS-CoV-2 of 28 Strychnos extracts, Phytotherapy Research, doi:10.1002/ptr.7394
Maisonnasse, Guedj, Contreras, Behillil, Solas et al., Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates, Nature, doi:10.1038/s41586-020-2558-4
Okour, Al-Kofahi, Austin, Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome, Journal of Pharmacokinetics and Pharmacodynamics, doi:10.1007/s10928-020-09689-x
Saber-Moghaddam, Salari, Hejazi, Amini, Taherzadeh et al., Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial, Phytotherapy Research, doi:10.1002/ptr.7004
Soni, Mehta, Ratre, Tiwari, Amit et al., Curcumin, a traditional spice component, can hold the promise against COVID-19?, European Journal of Pharmacology, doi:10.1016/j.ejphar.2020.173551
Tutunchi, Naeini, Ostadrahimi, Hosseinzadeh-Attar, Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19, Phytotherapy Research, doi:10.1002/ptr.6781
Zahedipour, Hosseini, Sathyapalan, Majeed, Jamialahmadi et al., Potential effects of curcumin in the treatment of COVID-19 infection, Phytotherapy Research, doi:10.1002/ptr.6738
Zaidi, Dehgani-Mobaraki, The mechanisms of action of ivermectin against SARS-CoV-2-An extensive review, The Journal of Antibiotics, doi:10.1038/s41429-021-00491-6
{ 'indexed': {'date-parts': [[2022, 4, 9]], 'date-time': '2022-04-09T09:42:09Z', 'timestamp': 1649497329250}, 'reference-count': 10, 'publisher': 'Wiley', 'license': [ { 'start': { 'date-parts': [[2022, 4, 9]], 'date-time': '2022-04-09T00:00:00Z', 'timestamp': 1649462400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'http://onlinelibrary.wiley.com/termsAndConditions#vor'}, { 'start': { 'date-parts': [[2022, 4, 9]], 'date-time': '2022-04-09T00:00:00Z', 'timestamp': 1649462400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'http://doi.wiley.com/10.1002/tdm_license_1.1'}], 'funder': [ { 'DOI': '10.13039/501100006673', 'name': 'Fonds Léon Fredericq', 'doi-asserted-by': 'publisher', 'award': ['2020‐2021 ‐ 113 ‐ Sub. F/E']}], 'content-domain': {'domain': ['onlinelibrary.wiley.com'], 'crossmark-restriction': True}, 'short-container-title': ['Phytotherapy Research'], 'DOI': '10.1002/ptr.7463', 'type': 'journal-article', 'created': {'date-parts': [[2022, 4, 9]], 'date-time': '2022-04-09T09:04:03Z', 'timestamp': 1649495043000}, 'update-policy': 'http://dx.doi.org/10.1002/crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': [ 'In vitro antiviral activity against\n' ' <scp>SARS‐CoV</scp>\n' ' ‐2 of common herbal medicinal extracts and their bioactive compounds'], 'prefix': '10.1002', 'author': [ { 'given': 'Kristi', 'family': 'Leka', 'sequence': 'first', 'affiliation': [ { 'name': 'Laboratory of Pharmacognosy, Center of Interdisciplinary ' 'Research on Medicines (CIRM) University of Liège Liège Belgium'}, { 'name': 'Center of Interdisciplinary Research on Medicines (CIRM) ' 'University of Liège Liège Belgium'}, { 'name': 'Laboratory of Veterinary Pathology, Fundamental and Applied ' 'Research for Animals &amp; Health (FARAH) University of Liège ' 'Liège Belgium'}]}, { 'given': 'Carla', 'family': 'Hamann', 'sequence': 'additional', 'affiliation': [ { 'name': 'Laboratory of Pharmacognosy, Center of Interdisciplinary ' 'Research on Medicines (CIRM) University of Liège Liège ' 'Belgium'}]}, { 'given': 'Pauline', 'family': 'Desdemoustier', 'sequence': 'additional', 'affiliation': [ { 'name': 'Center of Interdisciplinary Research on Medicines (CIRM) ' 'University of Liège Liège Belgium'}]}, { 'given': 'Michel', 'family': 'Frédérich', 'sequence': 'additional', 'affiliation': [ { 'name': 'Laboratory of Pharmacognosy, Center of Interdisciplinary ' 'Research on Medicines (CIRM) University of Liège Liège ' 'Belgium'}]}, { 'given': 'Mutien‐Marie', 'family': 'Garigliany', 'sequence': 'additional', 'affiliation': [ { 'name': 'Laboratory of Veterinary Pathology, Fundamental and Applied ' 'Research for Animals &amp; Health (FARAH) University of Liège ' 'Liège Belgium'}]}, { 'ORCID': 'http://orcid.org/0000-0002-4052-6336', 'authenticated-orcid': False, 'given': 'Allison', 'family': 'Ledoux', 'sequence': 'additional', 'affiliation': [ { 'name': 'Laboratory of Pharmacognosy, Center of Interdisciplinary ' 'Research on Medicines (CIRM) University of Liège Liège ' 'Belgium'}]}], 'member': '311', 'published-online': {'date-parts': [[2022, 4, 9]]}, 'reference': [ {'key': 'e_1_2_1_6_2_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6887'}, { 'issue': '1', 'key': 'e_1_2_1_6_3_1', 'doi-asserted-by': 'crossref', 'first-page': '16', 'DOI': '10.1016/S1473-3099(21)00768-4', 'article-title': 'Transmissibility of SARS‐CoV‐2 among fully vaccinated individuals', 'volume': '22', 'author': 'Franco‐Paredes C.', 'year': '2022', 'journal-title': 'The Lancet Infectious Diseases'}, {'key': 'e_1_2_1_6_4_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.7394'}, {'key': 'e_1_2_1_6_5_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41586-020-2558-4'}, { 'key': 'e_1_2_1_6_6_1', 'doi-asserted-by': 'crossref', 'first-page': '187', 'DOI': '10.1007/s10928-020-09689-x', 'article-title': 'Hydroxychloroquine and azithromycin as potential treatments for ' 'COVID‐19; clinical status impacts the outcome', 'volume': '47', 'author': 'Okour M.', 'year': '2020', 'journal-title': 'Journal of Pharmacokinetics and Pharmacodynamics'}, {'key': 'e_1_2_1_6_7_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.7004'}, { 'key': 'e_1_2_1_6_8_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ejphar.2020.173551'}, {'key': 'e_1_2_1_6_9_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6781'}, {'key': 'e_1_2_1_6_10_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6738'}, { 'key': 'e_1_2_1_6_11_1', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41429-021-00491-6'}], 'container-title': ['Phytotherapy Research'], 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7463', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://onlinelibrary.wiley.com/doi/full-xml/10.1002/ptr.7463', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://onlinelibrary.wiley.com/doi/pdf/10.1002/ptr.7463', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 4, 9]], 'date-time': '2022-04-09T09:04:07Z', 'timestamp': 1649495047000}, 'score': 1, 'resource': {'primary': {'URL': 'https://onlinelibrary.wiley.com/doi/10.1002/ptr.7463'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2022, 4, 9]]}, 'references-count': 10, 'alternative-id': ['10.1002/ptr.7463'], 'URL': 'http://dx.doi.org/10.1002/ptr.7463', 'archive': ['Portico'], 'relation': {}, 'ISSN': ['0951-418X', '1099-1573'], 'issn-type': [{'value': '0951-418X', 'type': 'print'}, {'value': '1099-1573', 'type': 'electronic'}], 'subject': ['Pharmacology'], 'published': {'date-parts': [[2022, 4, 9]]}, 'assertion': [ { 'value': '2022-02-14', 'order': 0, 'name': 'received', 'label': 'Received', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2022-03-25', 'order': 1, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'publication_history', 'label': 'Publication History'}}, { 'value': '2022-04-09', 'order': 2, 'name': 'published', 'label': 'Published', 'group': {'name': 'publication_history', 'label': 'Publication History'}}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit